Hikma Pharmaceutical reported 2.14B in Current Assets for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Artemis Alpha ATS:LN 10.02M 2.53M
AstraZeneca AZN:LN 20.92B 1.73B
Bayer BAYN:GR 39.55B 1.3B
Fresenius FRE:GR € 18818M 816M
Galapagos GLPG:NA 4.53B 217.51M
Genmab GEN:DC 23.18B 439M
GlaxoSmithKline GSK:LN 54.19B 25.2B
Hikma Pharmaceutical HIK:LN 2.14B 50M
Lonza Group LONN:SW 5.7B 251M
Merck MRK:GR € 12416M 1331M
Orion ORNBV:FH 624.8M 120.8M
Recordati REC:IM 1.26B 301.63M